Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Hydroxyzine Dosage for Adults

Dosage Considerations

  • The British Journal of Dermatology recommends a dosage of 10-50 mg at bedtime as a sedating antihistamine for patients with pruritus and dermatological conditions, complementing non-sedating antihistamines during the day 1, 2
  • In patients with urticaria, adding hydroxyzine to a non-sedating antihistamine during the day can help improve sleep 3

Special Considerations

  • For patients with moderate renal insufficiency (creatinine clearance 10-20 mL/min), the dosage should be reduced by half, as recommended by the British Journal of Dermatology 1, 4
  • In patients with severe hepatic disease, hydroxyzine should be avoided due to its sedative effects, according to the British Journal of Dermatology 1, 4
  • For elderly adults, lower dosages should be considered due to the increased risk of sedative effects, as suggested by the British Journal of Dermatology 5

Contraindications and Precautions

  • The British Journal of Dermatology advises against taking hydroxyzine with other sedative or central nervous system depressant medications 2
  • Hydroxyzine is contraindicated during the early stages of pregnancy, as recommended by the British Journal of Dermatology 1, 4
  • Prolonged use as monotherapy is not recommended due to concerns about reduced concentration and performance, according to the British Journal of Dermatology 3

Hydroxyzine Treatment Duration and Usage

Treatment Guidelines

  • The British Journal of Dermatology advises against extended monotherapy with hydroxyzine, favoring its use as a nighttime adjunct to non-sedating antihistamines 6
  • For mild to moderate itching, hydroxyzine can be used for a duration of 2-4 weeks, with a typical dosing schedule of 10 mg every 6 hours as needed 7
  • The British Journal of Dermatology recommends transitioning to non-sedating antihistamines for long-term management, and avoiding hydroxyzine in severe liver disease due to its sedating effects 6
  • Hydroxyzine is contraindicated in early pregnancy, and its dose should be reduced by half in moderate renal impairment 6

Dosing and Administration

  • A dosing schedule of 10 mg every 6 hours as needed can be used for mild symptoms, while 25-50 mg at bedtime can be used for sedation and nighttime symptom control 7

Hydroxyzine Dosing Guidelines

Special Considerations

  • The American Academy of Allergy, Asthma, and Immunology notes that older adults are at high risk for side effects from first-generation antihistamines, particularly with pre-existing conditions like prostatic hypertrophy, elevated intraocular pressure, or cognitive impairment 8
  • The Journal for ImmunoTherapy of Cancer recommends avoiding concomitant use with other CNS depressants, as this enhances performance impairment and sedation 9
  • The American Academy of Allergy, Asthma, and Immunology also notes that hydroxyzine causes 80% sedation rates compared to 50% with diphenhydramine and 60-73% with promethazine 8
  • For steroid-refractory pruritus in immune checkpoint inhibitor toxicity, the Journal for ImmunoTherapy of Cancer suggests hydroxyzine 10-25 mg QID or at bedtime can be combined with topical corticosteroids 9
  • The American Academy of Allergy, Asthma, and Immunology notes that the anticholinergic effects of hydroxyzine provide better control of rhinorrhea compared to second-generation antihistamines 8

Hydroxyzine Guideline Summary

Special Population Considerations

  • Elderly adults are at high risk for side effects from hydroxyzine, particularly sedative effects, and should be started at the low end of the dosing range due to decreased hepatic, renal, or cardiac function, and hydroxyzine is listed among anticholinergic medications that should be avoided in older adults due to CNS impairment, as recommended by the Mayo Clinic 10
  • Hydroxyzine is specifically listed as a medication to deprescribe in older adults due to fall risk, as recommended by the Mayo Clinic 10

Clinical Pearls and Common Pitfalls

  • Hydroxyzine's sedating and anticholinergic properties make it inappropriate for use in delirium management, as noted in guidelines from the Annals of Oncology 11, 12

Hydroxyzine Dosing and Safety Considerations

Standard Dosing Regimens

  • The British Journal of Dermatology recommends 50mg of hydroxyzine at bedtime as the most commonly used regimen for conditions like urticaria or pruritus, minimizing daytime sedation and performance impairment while providing symptom control 13
  • Bedtime dosing provides sustained effects into the next day due to the long half-life of hydroxyzine, according to the British Journal of Dermatology 13

Critical Safety Considerations

  • The Journal of Allergy and Clinical Immunology warns that hydroxyzine causes sedation and performance impairment even when patients deny subjective drowsiness, and drivers taking hydroxyzine are 1.5 times more likely to be responsible for fatal automobile accidents 14
  • Multiple daily dosing of hydroxyzine significantly increases the risk of daytime drowsiness, performance impairment, and cognitive effects, as reported by the Journal of Allergy and Clinical Immunology 14
  • Concomitant use of hydroxyzine with other sedatives dramatically enhances performance impairment, according to the Journal of Allergy and Clinical Immunology 14
  • The Journal of Allergy and Clinical Immunology advises to use caution in patients taking other anticholinergic drugs, particularly elderly patients with prostatic hypertrophy, elevated intraocular pressure, or cognitive impairment 14

Common Pitfalls to Avoid

  • The Journal of Allergy and Clinical Immunology recommends avoiding AM/PM split dosing of hydroxyzine and non-sedating antihistamines as a cost-saving strategy, as hydroxyzine's long half-life causes significant daytime impairment even with bedtime-only dosing 14
  • The Journal of Allergy and Clinical Immunology warns that performance impairment can persist without subjective awareness of drowsiness, and tolerance may not develop 14
  • Hydroxyzine impairs learning, work performance, and increases occupational accidents, and should be avoided in patients requiring optimal cognitive function, as reported by the Journal of Allergy and Clinical Immunology 14

Hydroxyzine Dosing and Safety Recommendations

Adult Dosing for Pruritus and Urticaria

  • For adult patients with pruritus or urticaria, prescribe hydroxyzine 10 – 50 mg at bedtime as an adjunct to a non‑sedating antihistamine; this regimen provides nighttime symptom control while minimizing daytime sedation. 15
  • Hydroxyzine should not be used as first‑line monotherapy for these conditions because its sedating properties and associated performance impairment outweigh the benefits when used alone. 15

Dose Adjustments in Special Populations

  • Renal impairment – In adults with moderate renal dysfunction (creatinine clearance ≈ 10–20 mL/min), reduce the total daily hydroxyzine dose by 50 %. 15
  • Severe renal impairment – In adults with severe renal dysfunction (creatinine clearance < 10 mL/min), avoid hydroxyzine entirely. 15
  • Severe hepatic disease – Hydroxyzine must be avoided in patients with severe liver disease because of the risk of excessive sedation and potential hepatic encephalopathy. 15
  • Elderly patients – Initiate therapy at the low end of the adult dosing range (10 mg at bedtime) due to age‑related declines in hepatic, renal, and cardiac function and the heightened risk of falls, fractures, anticholinergic effects, and cognitive impairment. 15

Contraindications

  • Early pregnancy – Hydroxyzine is the only antihistamine explicitly contraindicated during the first trimester of pregnancy. 15
  • Severe hepatic disease – Absolute contraindication; hydroxyzine should not be administered. 15
  • Severe renal impairment – Absolute contraindication; hydroxyzine should not be administered. 15

Practical Dosing Algorithm for Pruritus/Urticaria with Sleep Disturbance

  • Begin treatment with a non‑sedating antihistamine (e.g., loratadine 10 mg) taken in the morning.
  • If nighttime itching persists, add hydroxyzine 10 – 50 mg at bedtime.
  • Adjust the hydroxyzine dose according to tolerability and renal function, halving the dose in moderate renal impairment and starting at 10 mg in elderly patients. 15

Hydroxyzine Use in Acute Urticaria: Evidence‑Based Recommendations

Dosing Recommendations for Adults

  • Hydroxyzine 10–50 mg taken at bedtime may be added to a non‑sedating second‑generation H1‑antihistamine to control nighttime symptoms, but it should not be used as first‑line monotherapy because sedation and performance impairment outweigh any benefit. 16
  • The recommended adult adjunctive dose is 10–50 mg at bedtime when combined with a daytime non‑sedating antihistamine. 16

Safety Considerations

Contraindications & Dose Adjustments

  • Hydroxyzine is contraindicated in patients with severe hepatic disease due to the risk of excessive sedation and possible hepatic encephalopathy. 16
  • In patients with moderate renal impairment (creatinine clearance 10–20 mL/min), the hydroxyzine dose should be reduced by 50 %. 16

Performance & Occupational Risks

  • Long‑term use of hydroxyzine as monotherapy is discouraged because it can impair concentration and work performance, increasing the risk of occupational accidents. 16

Treatment Algorithm for Urticaria

Initial Management

  • Begin therapy with a non‑sedating second‑generation H1‑antihistamine (e.g., cetirizine 10 mg or loratadine 10 mg) taken once daily in the morning. 16
  • Offer patients a choice of at least two different non‑sedating antihistamines, as individual responses may vary. 16

Escalation When Response Is Inadequate (2–4 weeks)

  • Increase the dose of the non‑sedating antihistamine up to four‑fold (e.g., cetirizine up to 40 mg daily) before considering the addition of a sedating agent. 16

Adding Hydroxyzine for Persistent Nighttime Symptoms

  • If nighttime itching and sleep disturbance persist despite optimized non‑sedating antihistamine dosing, add hydroxyzine 10–50 mg at bedtime. 16
  • This adjunct does not improve overall urticaria control compared with higher‑dose non‑sedating antihistamines alone, although it may aid some patients in achieving better sleep. 16

Avoiding Inappropriate Use

  • Hydroxyzine should not be employed as a prolonged monotherapy because of its detrimental effects on cognition and daily functioning. 16

Hydroxyzine Safety Considerations in Skilled‑Nursing Residents

Sedation and Central‑Nervous‑System Effects

  • Hydroxyzine produces sedation in approximately 80 % of elderly skilled‑nursing patients and significantly prolongs reaction times even at standard dosing, increasing the risk of over‑sedation and falls. 17

Anticholinergic Risks

  • In older adults, the anticholinergic activity of hydroxyzine adds to that of other anticholinergic drugs, resulting in central‑nervous‑system impairment and delirium, visual disturbances, urinary retention, constipation, and a heightened risk of falls. 17
  • Hydroxyzine is specifically listed among anticholinergic medications that should be avoided or deprescribed in older adults. 17
  • When hydroxyzine is considered for a patient already receiving anticholinergic agents, clinicians should preferentially use alternative anxiolytic options such as selective serotonin reuptake inhibitors (SSRIs) rather than adding hydroxyzine. 17

Medication Review Recommendations

  • The European Heart Journal advises a mandatory review of a skilled‑nursing resident’s medication list for central‑nervous‑system depressants, QT‑prolonging agents, and anticholinergic drugs before initiating hydroxyzine therapy. 18
  • Tricyclic antidepressants are identified as anticholinergic agents that increase adverse risk when combined with hydroxyzine. 18

Assessment of Renal Function in Elderly Patients on Lithium and Hydroxyzine

Importance of Creatinine Clearance Calculation

First‑Line Management of Urticaria with Second‑Generation Antihistamines

  • Loratadine (a second‑generation antihistamine) should be used as the initial therapy for both acute and chronic urticaria, while diphenhydramine (a first‑generation antihistamine) must be avoided as monotherapy because its sedative and anticholinergic effects outweigh any clinical benefit. 20

Initiation and Choice of Agent

  • Begin treatment with loratadine 10 mg taken once daily for patients with urticaria. 20
  • Provide patients with at least two alternative second‑generation antihistamines (e.g., cetirizine, desloratadine, fexofenadine, levocetirizine, or loratadine) because individual response variability is common. 20

Dose Escalation When Response Is Inadequate

  • If symptoms persist after 2–4 weeks of standard dosing, increase loratadine up to four‑fold (maximum 40 mg daily) before adding any sedating agent, provided the anticipated benefit exceeds the risk. 20

Limited Role of Diphenhydramine

  • Diphenhydramine must not be employed as sole therapy for urticaria due to its pronounced sedation, performance impairment, and anticholinergic side‑effects. 20
  • When nocturnal itching remains despite optimized second‑generation antihistamine dosing, a single bedtime dose of diphenhydramine or hydroxyzine (10–50 mg) may be added solely to improve sleep. 20

Contraindications for Diphenhydramine/Hydroxyzine

  • Avoid use in patients with severe renal impairment (creatinine clearance < 10 mL/min). 20

General Adjunctive Measures

  • Identify and minimize aggravating factors such as overheating, stress, alcohol, aspirin, NSAIDs, and codeine. 20
  • Apply cooling antipruritic lotions (e.g., calamine or 1 % menthol in an aqueous cream) for symptomatic relief. 20
  • In aspirin‑sensitive individuals, avoid NSAIDs to prevent exacerbation of urticaria. 20

Safety Profile of Hydroxyzine When Used With Loratadine

Sedation and Performance Impairment

  • In patients receiving hydroxyzine (10–50 mg), approximately 80 % experience sedation and objective performance impairment, even when they report feeling alert. Evidence level: observational data. 21, 22
  • Drivers taking hydroxyzine are 1.5 times more likely to be responsible for fatal motor‑vehicle accidents compared with non‑users. Evidence level: epidemiologic cohort. 21
  • Hydroxyzine use is associated with reduced work performance, impaired learning in children, and a higher rate of occupational accidents. Evidence level: observational studies. 21, 23
  • The sedative effect of a bedtime‑only dose of hydroxyzine often persists into the following day because of its long half‑life and active metabolites. Evidence level: pharmacokinetic/clinical observation. 21

Anticholinergic Effects

  • Hydroxyzine commonly produces anticholinergic side‑effects such as dry mouth, urinary retention (including progression to acute retention), constipation, blurred vision, and increased intra‑ocular pressure. Evidence level: clinical safety reports. 21, 22
  • In older adults, hydroxyzine markedly raises the risk of falls, fractures, subdural hematomas, cognitive impairment, and delirium due to its anticholinergic properties. Evidence level: geriatric safety analyses. 21, 22

Contraindicated Situations & Practical Guidance

  • Hydroxyzine should not be prescribed for daytime use because its sedation and performance‑impairing effects are clinically significant even when taken at night. Evidence level: safety guideline based on clinical observations. 21
  • Chronic hydroxyzine therapy does not lead to tolerance of its sedative effects; impairment persists with continued use. Evidence level: longitudinal safety monitoring. 21

Note: All cited evidence originates from studies published in the Journal of Allergy and Clinical Immunology; no formal guideline society recommendation was identified for these specific safety statements.

REFERENCES

10
17